Stratifying low level Isoniazid resistance using additional intermediate drug concentration.

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Tuberculosis remains a significant global health challenge.
• Isoniazid (INH) is a first-line drug for tuberculosis treatment.
• Accurate susceptibility testing is crucial for effective treatment and preventing drug resistance.

Purpose of the Study:

• To evaluate the impact of additional drug concentrations on isoniazid susceptibility testing.
• To assess the discriminatory capacity of the minimum inhibitory concentration (MIC) method for Mycobacterium tuberculosis.
• To explore potential applications in specialized resistance studies.

Main Methods:

• Performed isoniazid susceptibility testing on 100 Mycobacterium tuberculosis isolates.
• Utilized the conventional minimum inhibitory concentration (MIC) method.
• Stratified testing using additional, specific drug concentrations.

Main Results:

• The introduction of extra drug concentrations did not substantially enhance the discriminatory power of the MIC method.
• The current methodology provides a baseline for assessing isoniazid resistance.
• The modified approach showed potential utility in specific research contexts.

Conclusions:

• Standard MIC-based isoniazid susceptibility testing for Mycobacterium tuberculosis offers limited gains with additional drug concentrations.
• The findings suggest that this refined method may be valuable for specialized investigations into cross-resistance.
• Further research is warranted to explore its application in understanding drug analogue interactions.